Matthew Speers
Algemeen Directeur bij IC-VEC Ltd.
Profiel
Matthew Speers has been Chief Executive Officer of IC-VEC Ltd.
since 2004.
Prior to joining IC-Vec, he was a Vice President of Plexus Ventures.
Previously, he worked for GlaxoSmithKline.
Mr. Speers has 20 years of experience in the pharmaceutical industry.
Actieve functies van Matthew Speers
| Bedrijven | Functie | Begin |
|---|---|---|
IC-VEC Ltd.
 IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Algemeen Directeur | 01-04-2004 |
Eerdere bekende functies van Matthew Speers
| Bedrijven | Functie | Einde |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GSK PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
IC-VEC Ltd.
IC-VEC Ltd. Miscellaneous Commercial ServicesCommercial Services IC-VEC Ltd. is a biotechnology firm and do research and development for non-viral drug delivery systems. The company's therapeutic areas are cancer and liver diseases. IC-VEC plans to use its technology to develop DNA based and cancer vaccines. The company was founded in December 2001 by Andrew Miller and is headquartered in London, UK | Commercial Services |
